• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别、血清学状态和吸烟对类风湿关节炎相关间质性肺疾病亚型风险的影响。

Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis-Associated Interstitial Lung Disease Subtypes.

作者信息

McDermott Gregory C, Hayashi Keigo, Juge Pierre-Antoine, Gill Ritu, Byrne Suzanne, Gagne Staci, Wang Xiaosong, Paudel Misti L, Moll Matthew, Cho Michael H, Vanni Kathleen, Kowalski Emily, Qian Grace, Bade Katarina, Saavedra Alene, Kawano Yumeko, DiIorio Michael, Wolfgang Taylor, Kim Edy Y, Dellaripa Paul F, Weinblatt Michael E, Shadick Nancy, Doyle Tracy J, Sparks Jeffrey A

机构信息

Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Brigham and Women's Hospital, Boston, Massachusetts.

出版信息

Arthritis Care Res (Hoboken). 2025 Feb;77(2):185-194. doi: 10.1002/acr.25432. Epub 2024 Oct 16.

DOI:10.1002/acr.25432
PMID:39257341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11772125/
Abstract

OBJECTIVE

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) includes multiple subtypes with varying histopathology, prognosis, and potential treatments. Limited research has investigated risk factors for different RA-ILD subtypes. Therefore, we examined demographic, serologic, and lifestyle associations with RA-ILD subtypes.

METHODS

We systematically identified RA-ILD cases and RA controls without ILD (RA-noILD) in the Brigham RA Sequential Study and Mass General Brigham Biobank RA cohort. We determined RA-ILD subtype (usual interstitial pneumonia [UIP], nonspecific interstitial pneumonia [NSIP], and other/indeterminate) through chest high-resolution computed tomography imaging pattern. We investigated associations of demographic, lifestyle, and serologic factors with major RA-ILD subtypes using multivariable logistic regression.

RESULTS

Among 3,328 patients with RA, we identified 208 RA-ILD cases and 547 RA-noILD controls. RA-UIP was associated with older age (odds ratio [OR] 1.03 per year, 95% confidence interval [95% CI] 1.01-1.05), male sex (OR 2.15, 95% CI 1.33-3.48), and seropositivity (OR 2.08, 95% CI 1.24-3.48), whereas RA-NSIP was significantly associated only with seropositive status (OR 3.21, 95% CI 1.36-7.56). Nonfibrotic ILDs were significantly associated with smoking (OR 2.81, 95% CI 1.52-5.21). Having three RA-ILD risk factors (male, seropositive, smoking) had an OR of 6.89 (95% CI 2.41-19.7) for RA-UIP compared with having no RA-ILD risk factors.

CONCLUSION

Older age, seropositivity, and male sex were strongly associated with RA-UIP, whereas RA-related autoantibodies were associated with RA-NSIP. These findings suggest RA-ILD sex differences may be driven by RA-UIP and emphasize the importance of further studies to clarify RA-ILD heterogeneity and optimize screening and treatment approaches.

摘要

目的

类风湿关节炎相关间质性肺疾病(RA - ILD)包括多种具有不同组织病理学、预后和潜在治疗方法的亚型。针对不同RA - ILD亚型的危险因素进行研究的较少。因此,我们研究了人口统计学、血清学和生活方式与RA - ILD亚型之间的关联。

方法

我们在布莱根妇女医院类风湿关节炎序列研究和麻省总医院布莱根生物样本库类风湿关节炎队列中系统地识别出RA - ILD病例和无ILD的类风湿关节炎对照(RA - noILD)。我们通过胸部高分辨率计算机断层扫描成像模式确定RA - ILD亚型(寻常型间质性肺炎[UIP]、非特异性间质性肺炎[NSIP]以及其他/不确定型)。我们使用多变量逻辑回归研究人口统计学、生活方式和血清学因素与主要RA - ILD亚型之间的关联。

结果

在3328例类风湿关节炎患者中,我们识别出208例RA - ILD病例和547例RA - noILD对照。RA - UIP与年龄较大(比值比[OR]为每年1.03,95%置信区间[95%CI]为1.01 - 1.05)、男性(OR为2.15,95%CI为1.33 - 3.48)以及血清学阳性(OR为2.08,95%CI为1.24 - 3.48)相关,而RA - NSIP仅与血清学阳性状态显著相关(OR为3.21,95%CI为1.36 - 7.56)。非纤维化ILD与吸烟显著相关(OR为2.81,95%CI为1.52 - 5.21)。与无RA - ILD危险因素相比,具有三种RA - ILD危险因素(男性、血清学阳性、吸烟)的患者患RA - UIP的OR为6.89(95%CI为2.41 - 19.7)。

结论

年龄较大、血清学阳性和男性与RA - UIP密切相关,而类风湿关节炎相关自身抗体与RA - NSIP相关。这些发现表明RA - ILD的性别差异可能由RA - UIP驱动,并强调进一步研究以阐明RA - ILD异质性以及优化筛查和治疗方法的重要性。

相似文献

1
Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis-Associated Interstitial Lung Disease Subtypes.性别、血清学状态和吸烟对类风湿关节炎相关间质性肺疾病亚型风险的影响。
Arthritis Care Res (Hoboken). 2025 Feb;77(2):185-194. doi: 10.1002/acr.25432. Epub 2024 Oct 16.
2
Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.类风湿关节炎相关间质性肺疾病:关联、预后因素以及生理和放射学特征——一项大型多中心英国研究。
Rheumatology (Oxford). 2014 Sep;53(9):1676-82. doi: 10.1093/rheumatology/keu165. Epub 2014 Apr 23.
3
Increased circulating Wnt5a protein in patients with rheumatoid arthritis-associated interstitial pneumonia (RA-ILD).类风湿关节炎相关间质性肺病(RA-ILD)患者循环 Wnt5a 蛋白增加。
Immunobiology. 2019 Jul;224(4):551-559. doi: 10.1016/j.imbio.2019.04.006. Epub 2019 Apr 30.
4
Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.与类风湿关节炎相关的间质性肺疾病患者死亡的相关因素:系统评价和荟萃分析。
Respir Res. 2021 Oct 11;22(1):264. doi: 10.1186/s12931-021-01856-z.
5
Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.重新解读类风湿关节炎相关间质性肺疾病的证据以理解其病因。
Curr Rheumatol Rev. 2019;15(4):277-289. doi: 10.2174/1573397115666190116102451.
6
Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes.与其他亚型相比,类风湿关节炎相关的普通型间质性肺炎的疾病病程多变。
BMC Pulm Med. 2016 Jul 27;16(1):107. doi: 10.1186/s12890-016-0269-2.
7
High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival.类风湿关节炎相关间质性肺疾病中寻常型间质性肺炎的高分辨率计算机断层扫描模式:与生存率的关系。
Respir Med. 2017 May;126:100-104. doi: 10.1016/j.rmed.2017.03.027. Epub 2017 Mar 30.
8
Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.类风湿关节炎疾病活动度预测新发病的临床明显类风湿关节炎相关间质性肺病:一项前瞻性队列研究。
Arthritis Rheumatol. 2019 Sep;71(9):1472-1482. doi: 10.1002/art.40904. Epub 2019 Aug 4.
9
Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.自身免疫性间质性肺疾病的临床特征和自然病程:一项单中心经验。
Lung. 2019 Dec;197(6):709-713. doi: 10.1007/s00408-019-00276-7. Epub 2019 Oct 3.
10
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.类风湿关节炎相关间质性肺疾病进展的危险因素:临床特征、生物标志物和治疗选择。
Semin Arthritis Rheum. 2022 Aug;55:152004. doi: 10.1016/j.semarthrit.2022.152004. Epub 2022 Apr 11.

本文引用的文献

1
Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease.类风湿关节炎-间质性肺病患者外周血白细胞端粒较短。
Thorax. 2024 Jan 18;79(2):182-185. doi: 10.1136/thorax-2023-220022.
2
Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease.抗纤维化药物治疗类风湿关节炎相关间质性肺疾病的疗效和耐受性。
Semin Arthritis Rheum. 2024 Feb;64:152312. doi: 10.1016/j.semarthrit.2023.152312. Epub 2023 Nov 24.
3
Prevalence and mortality associations of interstitial lung abnormalities in rheumatoid arthritis within a multicentre prospective cohort of smokers.
在一个多中心前瞻性吸烟人群队列中,类风湿关节炎的间质性肺异常的流行率和死亡率相关性。
Rheumatology (Oxford). 2023 Oct 23;62(SI3):SI286-SI295. doi: 10.1093/rheumatology/kead277.
4
Clinical Characteristics and Predictors of the Recurrence of Organizing Pneumonia Associated With Rheumatoid Arthritis.类风湿关节炎相关机化性肺炎复发的临床特征及预测因素。
J Rheumatol. 2023 Nov;50(11):1406-1413. doi: 10.3899/jrheum.2023-0037. Epub 2023 Aug 1.
5
Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: A systematic review and meta-analysis.抗纤维化药物治疗 CTD-ILD 和 RA-ILD 的疗效和安全性:系统评价和荟萃分析。
Respir Med. 2023 Sep;216:107329. doi: 10.1016/j.rmed.2023.107329. Epub 2023 Jun 12.
6
Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory.类风湿关节炎相关间质性肺病的治疗结果:一项真实世界、多中心研究免疫抑制对肺功能轨迹的影响。
Chest. 2023 Apr;163(4):861-869. doi: 10.1016/j.chest.2022.11.035. Epub 2022 Dec 5.
7
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.吡非尼酮治疗类风湿关节炎相关间质性肺疾病患者的安全性、耐受性和疗效:一项随机、双盲、安慰剂对照、2 期研究。
Lancet Respir Med. 2023 Jan;11(1):87-96. doi: 10.1016/S2213-2600(22)00260-0. Epub 2022 Sep 5.
8
A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease.用于检测亚临床类风湿关节炎相关间质性肺病的风险评分。
Arthritis Rheumatol. 2022 Nov;74(11):1755-1765. doi: 10.1002/art.42162. Epub 2022 Oct 5.
9
Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset.MUC5B 启动子变异与间质性肺病和类风湿关节炎发病时间的关联。
Rheumatology (Oxford). 2022 Nov 28;61(12):4915-4923. doi: 10.1093/rheumatology/keac152.
10
Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Population-Based Cohort.临床和亚临床类风湿关节炎相关间质性肺病的发病率、危险因素和死亡率:一项基于人群的队列研究。
Arthritis Care Res (Hoboken). 2022 Dec;74(12):2042-2049. doi: 10.1002/acr.24856. Epub 2022 Aug 10.